Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Gallowitsch

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
European Journal of Nuclear Medicine|May 15, 1998
Attenuation-corrected thallium-201 single-photon emission tomography using a gadolinium-153 moving line source: clinical value and the impact of attenuation correction on the extent and severity of perfusion abnormalitiesH J Gallowitsch, J Sykora, P Mikosch, et al.
Nuklearmedizin. Nuclear Medicine|September 4, 2008
Bone- and bone marrow scintigraphy in Gaucher disease type 1P Mikosch, F Zitter, H J Gallowitsch, et al.
Thyroid : Official Journal of the American Thyroid Association|June 14, 2003
Bone metabolism in patients with differentiated thyroid carcinoma receiving suppressive levothyroxine treatmentP Mikosch, B Obermayer-Pietsch, R Jost, et al.
Clinical Nuclear Medicine|January 1, 1997
Radioimmunoscintigraphy with Tc-99m labeled monoclonal antibody 170H.82 in suspected primary, recurrent, or metastatic breast cancerP Lind, H J Gallowitsch, P Mikosch, et al.
Nuklearmedizin. Nuclear Medicine|December 18, 2007
Sentinel node SPECT-CT in breast cancer. Can we expect any additional and clinically relevant information?H-J Gallowitsch, P Kraschl, I Igerc, et al.
Thyroid : Official Journal of the American Thyroid Association|May 15, 2004
Descriptive epidemiology of thyroid carcinoma in Carinthia, Austria: 1984-2001. Histopathologic features and tumor classification of 734 cases under elevated general iodination of table salt since 1990: population-based age-stratified analysis on thyroid carcinoma incidenceI Gomez Segovia, H J Gallowitsch, E Kresnik, et al.
Acta Medica Austriaca|May 17, 2000
The role of F-18FDG PET in thyroid cancerP Lind, G Kumnig, S Matschnig, et al.
Thyroid : Official Journal of the American Thyroid Association|February 13, 2002
Vocal cord muscle activity as a drawback to FDG-PET in the followup of differentiated thyroid cancerI Igerc, G Kumnig, M Heinisch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 26, 1998
Thallium-201 uptake with negative iodine-131 scintigraphy and serum thyroglobulin in metastatic oxyphilic papillary thyroid carcinomaW Harder, P Lind, M Molnar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 28, 1997
Technetium-99m-tetrofosmin uptake in sarcoidosis stage ID Tschabitscher, H J Gallowitsch, P Mikosch, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
European Journal of Nuclear Medicine|May 15, 1998
Attenuation-corrected thallium-201 single-photon emission tomography using a gadolinium-153 moving line source: clinical value and the impact of attenuation correction on the extent and severity of perfusion abnormalitiesH J Gallowitsch, J Sykora, P Mikosch, et al.
Nuklearmedizin. Nuclear Medicine|September 4, 2008
Bone- and bone marrow scintigraphy in Gaucher disease type 1P Mikosch, F Zitter, H J Gallowitsch, et al.
Thyroid : Official Journal of the American Thyroid Association|June 14, 2003
Bone metabolism in patients with differentiated thyroid carcinoma receiving suppressive levothyroxine treatmentP Mikosch, B Obermayer-Pietsch, R Jost, et al.
Clinical Nuclear Medicine|January 1, 1997
Radioimmunoscintigraphy with Tc-99m labeled monoclonal antibody 170H.82 in suspected primary, recurrent, or metastatic breast cancerP Lind, H J Gallowitsch, P Mikosch, et al.
Nuklearmedizin. Nuclear Medicine|December 18, 2007
Sentinel node SPECT-CT in breast cancer. Can we expect any additional and clinically relevant information?H-J Gallowitsch, P Kraschl, I Igerc, et al.
Thyroid : Official Journal of the American Thyroid Association|May 15, 2004
Descriptive epidemiology of thyroid carcinoma in Carinthia, Austria: 1984-2001. Histopathologic features and tumor classification of 734 cases under elevated general iodination of table salt since 1990: population-based age-stratified analysis on thyroid carcinoma incidenceI Gomez Segovia, H J Gallowitsch, E Kresnik, et al.
Acta Medica Austriaca|May 17, 2000
The role of F-18FDG PET in thyroid cancerP Lind, G Kumnig, S Matschnig, et al.
Thyroid : Official Journal of the American Thyroid Association|February 13, 2002
Vocal cord muscle activity as a drawback to FDG-PET in the followup of differentiated thyroid cancerI Igerc, G Kumnig, M Heinisch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 26, 1998
Thallium-201 uptake with negative iodine-131 scintigraphy and serum thyroglobulin in metastatic oxyphilic papillary thyroid carcinomaW Harder, P Lind, M Molnar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 28, 1997
Technetium-99m-tetrofosmin uptake in sarcoidosis stage ID Tschabitscher, H J Gallowitsch, P Mikosch, et al.
Pageof 7